GlassScriptPhysician profile
Neelima Katragadda
NPI 1851435101
$9,385.86
in general payments reported to CMS, 2019-2025
42 companies · $729 in 2025
The $729 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $577 · 2020: $477 · 2021: $562 · 2022: $647 · 2023: $704 · 2024: $5,690 · 2025: $729.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,019 · Food and Beverage: $2,264 · Travel and Lodging: $1,840.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,019.27 |
| Food and Beverage | $2,263.60 |
| Travel and Lodging | $1,840.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,934.41 | 2024 | |
| Abbvie INC. | $677.12 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $406.88 | 2019-2025 | |
| Amgen INC. | $359.61 | 2019-2025 | Evenity, Prolia |
| Astellas Pharma US INC | $337.00 | 2019-2025 | Veozah |
| Exeltis, USA INC. | $259.25 | 2019-2025 | Slynd |
| Hologic Sales and Service, LLC | $233.40 | 2019-2025 | Acessa Provu System, Sonata Sonography-Guided Transcervical Fibroid Ablation System, Aptima |
| Organon LLC | $186.31 | 2021-2025 | Nexplanon, Jada System |
| Pfizer INC. | $178.84 | 2019-2024 | |
| Shield Therapeutics INC | $171.81 | 2023-2024 | Accrufer |
| Radius Health, INC. | $163.27 | 2020-2025 | Tymlos |
| Mayne Pharma Commercial LLC | $160.95 | 2022-2025 | |
| Coopersurgical, INC. | $143.50 | 2019-2025 | Paragard T 380a, Paragard T 380a, Endosee |
| Myovant Sciences INC. | $119.10 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $98.63 | 2023-2025 | Myfembree |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $71.52 | 2019-2020 | |
| Agile Therapeutics, INC. | $61.38 | 2021-2022 | |
| Novo Nordisk INC | $59.51 | 2023-2024 | |
| Exact Sciences Corporation | $59.27 | 2024-2025 | Cologuard Collection Kit |
| Lundbeck LLC | $56.61 | 2022 | |
| Lupin INC. | $53.70 | 2019-2021 | |
| Davol INC. | $47.23 | 2023 | Arista Ah Flexitip |
| Mimedx Group, INC. | $46.82 | 2024 | |
| Millicent US INC | $46.08 | 2025 | Intrarosa, Femlyv, Femring |
| Amag Pharmaceuticals, INC. | $43.07 | 2019-2020 | |
| Meditrina | $42.47 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $39.84 | 2024-2025 | |
| Avion Pharmaceuticals | $38.61 | 2020-2021 | |
| Duchesnay USA Incorporated | $35.78 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $32.10 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $26.95 | 2019 | |
| Mylan Pharmaceuticals INC. | $25.93 | 2021 | |
| Allergan, INC. | $23.75 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $22.02 | 2024 | Enhertu |
| Biogen, INC. | $19.98 | 2025 | Zurzuvae |
| Optumhealth Care Solutions, LLC | $17.17 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Daiichi Sankyo INC. | $16.84 | 2020 | |
| Medtronic, INC. | $16.81 | 2023 | Kyphon Express II Kyphopak Tray |
| Tactile Systems Technology INC | $15.27 | 2020 | |
| Evofem Biosciences, INC. | $12.90 | 2021 | |
| Ferring Pharmaceuticals INC. | $12.40 | 2019 | |
| Minerva Surgical, INC | $11.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neelima Katragadda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.